Recent Company News

• 07:44 PM ET Oct 21, 2025
  

  Demant to sell Oticon Medical to Impilo for total contractual consideration of up to DKK600M (DKK 240.80, 0.00)

• 11:55 AM ET Oct 09, 2025
  

  Demant Chair Niels Christiansen will not stand for re-election (DKK 230.20, 0.00)

• 06:48 AM ET Sep 25, 2025
  

  Trump administration initiates Section 232 investigations into medical devices and equipment, robotics and industrial machinery -- CNBC/Federal Register filings (yesterday post US-close)

• 08:07 AM ET Aug 26, 2025
  

  Lineage Cell Therapeutics announces research collaboration with William Demant Invest to develop ReSonance (ANP1) for hearing loss ($1.17, 0.00)

• 04:58 AM ET Aug 13, 2025
  

  Street Takeaways - Demant H1 Earnings (DKK 252.00, -1.40)

• 02:55 AM ET Aug 13, 2025
  

  StreetAccount Summary - European pre-market trading update

• 11:57 AM ET Aug 12, 2025
  

  StreetAccount Metrics Recap - Demant Q2 Sales (DKK 253.40, 0.00)

• 11:56 AM ET Aug 12, 2025
  

  Demant reports H1 EBIT before special items DKK1.85B vs consensus DKK1.98B; Outlook for 2025 revised for organic growth and EBIT (DKK 253.40, 0.00)

• 05:24 AM ET Aug 11, 2025
  

  StreetAccount Consensus Metrics Preview - Demant Q2 / H1 Earnings (DKK 257.60, +1.40)

• 01:53 AM ET Aug 11, 2025
  

  Demant upgraded to buy from hold at ABG Sundal Collier (DKK 256.20, 0.00)